Brottem John L.'s Form 4 filing
Outset Medical, Inc. (OM) · filed Mar 17, 2022
- Accession no.
- 0001484612-22-000027
- Filed
- Mar 17, 2022
- Trade date
- Mar 16-17, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $112.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brottem John L.CIK 0001823381 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 | Common Stock | SSaleDisposed | −1,392 | $39.77 | −$55,359.84 | 35,414 | Direct | |
| Mar 17, 2022 | Common Stock | SSaleDisposed | −1,400 | $40.46 | −$56,644 | 34,014 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.